Coloplast A/S - Interim Financial Report, 9M 2023/24 [Yahoo! Finance]
COLOPLAST AS SP/ADR (CLPBY)
NASDAQ:AMEX Investor Relations:
coloplast.com/investor-relations
Company Research
Source: Yahoo! Finance
Coloplast delivered 8% organic growth and an EBIT margin of 27% in Q3, with 11% growth in absolute EBIT Reported revenue in DKK grew 13% which includes 4%-points contribution from Kerecis (underlying growth of around 35%). Organic growth rates by business area: Ostomy Care 8%, Continence Care 8%, Voice and Respiratory Care 11%, Advanced Wound Care 13% (Advanced Wound Dressings 13%) and Interventional Urology 2%. Growth in Chronic Care was broad-based across regions and includes an improvement in growth in the US Ostomy Care business. Continence Care growth was driven by intermittent catheters, including significant contribution from the male Luja TM catheter. Launch of the female Luja catheter* is ongoing and has received positive customer feedback. Voice and Respiratory Care growth was driven by continued good momentum in both Laryngectomy and Tracheostomy. Strong quarter in Advanced Wound Dressings, reflecting continued good momentum and benefit from a lower baseline in Q3
Show less
Read more
Impact Snapshot
Event Time:
CLPBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLPBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLPBY alerts
High impacting COLOPLAST AS SP/ADR news events
Weekly update
A roundup of the hottest topics
CLPBY
News
- Coloplast A/S - Financial Calendar 2024-25 [Yahoo! Finance]Yahoo! Finance
- Tempo doses first patient with tissue scaffolds in cancer surgery trial [Yahoo! Finance]Yahoo! Finance
- Global Burn Care Market Size To Worth USD 4.88 Billion By 2033 | CAGR Of 7.3% [Yahoo! Finance]Yahoo! Finance
- Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.73% [Yahoo! Finance]Yahoo! Finance
- Coloplast A/S (CLPBF) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha